Springer Nature OAopen access
Chronic Kidney Disease (CKD): Systematic Review of the Cost Effectiveness of SGLT2 Inhibitors and Other Novel Nephroprotective Drugs
Medicine & Public Health, Pharmacoeconomics and Health Outcomes, Quality of Life Research, Health Economics, Health Administration, Public Health
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 203576
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.